Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group - Sung,R.J.; Tan,H.L.; Karagounis,L. (Am Heart J, 1995)